Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma

NCT03389477 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Palbociclib
DRUG: Cetuximab
DRUG: Cisplatin
RADIATION: Intensity-Modulated Radiation Therapy
PROCEDURE: Tumor biopsy
PROCEDURE: Peripheral blood draw

Sponsor

Washington University School of Medicine

Collaborators

[object Object]